✦ LIBER ✦

Gemifloxacin for the Treatment of Respiratory Tract Infections: In Vitro Susceptibility, Pharmacokinetics and Pharmacodynamics, Clinical Efficacy, and Safety

✍ Scribed by Dr. Sujata M. Bhavnani; Dr. David R. Andes

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of gemifloxacin 320

✍ Peter Ball; Thomas M File; Monique Twynholm; Timothy Henkel 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Continuous infusion of ticarcillin–clavu

✍ Munckhof, Wendy J.; Carney, John; Neilson, Gail; Neilson, John; Carroll, Julia; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Continuous vs. intermittent cefotaxime a

✍ A. R. H. Van Zanten; M. Oudijk; M. K. E. Nohlmans-Paulssen; Y. G. Van Der Meer; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB

Efficacy and safety of garenoxacin in th

✍ Makoto Ito; Yumiko Maruyama; Shigeyuki Murono; Naohiro Wakisaka; Satoru Kondo; M 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 254 KB

In vitro activity, pharmacokinetics, cli

✍ K. G. Naber; B. Bartosik-Wich; F. Sörgel; F. Gutzler 📂 Article 📅 1985 🏛 Springer-Verlag 🌐 English ⚖ 822 KB

In vitro activity, pharmacokinetics, cli

✍ K. G. Naber; B. Bartosik-Wich; F. Sörgel; F. Gutzler 📂 Article 📅 1986 🏛 Springer-Verlag 🌐 English ⚖ 802 KB